Product image of Noveze (Ezetimibe) supplied by GNH India

Noveze

Active Ingredient:
Ezetimibe
Origin:
EU

Noveze (Ezetimibe)

Ezetimibe, the active ingredient in Noveze, is a cholesterol absorption inhibitor presented as an oral tablet for oral use. It reduces elevated cholesterol levels by limiting intestinal absorption of dietary and biliary cholesterol, and is prescribed for patients with primary hyperlipidemia, familial hypercholesterolemia, or homozygous familial hypercholesterolemia who require additional lipid lowering.

GNH India supplies Noveze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, traceability and regulatory compliance across all markets, through rigorous manufacturing standards and validated distribution processes.

Manufacturer / TM Owner

Novatin Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ezetimibe is used to lower cholesterol by targeting intestinal absorption pathways in several lipid disorders.

  • Hypercholesterolemia: reduces LDL‑cholesterol levels when used alone or with statins.
  • Familial hypercholesterolemia: helps achieve target lipid levels in genetically predisposed patients.
  • Homozygous familial hypercholesterolemia: provides additional cholesterol reduction in severe cases.
  • Primary hyperlipidemia: lowers total cholesterol and LDL‑C as part of a comprehensive lipid‑lowering regimen.

How It Works

  • Ezetimibe selectively blocks the Niemann-Pick C1‑like 1 (NPC1L1) transporter located on the brush border of the small intestine, inhibiting the uptake of dietary and biliary cholesterol. This reduction in intestinal cholesterol absorption leads to decreased delivery of cholesterol to the liver, prompting up‑regulation of hepatic LDL receptors and increased clearance of LDL‑cholesterol from the bloodstream.

Side Effects

Ezetimibe is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Abdominal pain: mild discomfort in the stomach area.
  • Diarrhea: loose stools occurring intermittently.
  • Fatigue: feeling unusually tired.
  • Headache: mild to moderate head pain.
  • Nausea: sensation of unease in the stomach.

Serious or Rare Side Effects

  • Myopathy: muscle pain or weakness, potentially indicating muscle injury.
  • Elevated liver enzymes: signs of liver stress requiring monitoring.
  • Allergic reactions: rash, itching, swelling, or difficulty breathing.
  • Pancreatitis: severe abdominal pain possibly indicating pancreatic inflammation.
  • Severe hypersensitivity: anaphylactic symptoms requiring immediate medical attention.

Precautions & Warnings

Before initiating therapy, several precautions should be considered.

  • Monitor lipid profile: assess efficacy and safety regularly.
  • Assess liver function: check hepatic enzymes prior to and during treatment.
  • Evaluate renal function: adjust use in patients with severe kidney impairment.
  • Avoid use in active gallbladder disease: may exacerbate biliary conditions.
  • Store at ambient temperature: keep below 25°C, protect from moisture and light.

Avoid Interactions

Ezetimibe may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Cyclosporine: can increase ezetimibe plasma concentrations.
  • Bile acid sequestrants: may bind ezetimibe and reduce its absorption if taken simultaneously.
  • Strong CYP3A4 inducers: can lower ezetimibe exposure and effectiveness.

Moderate Interactions (Monitor Closely)

  • Statins: combined use may raise the risk of myopathy.
  • Warfarin: ezetimibe may affect INR, requiring closer coagulation monitoring.
  • Fibrates: potential additive effect on liver enzymes, necessitating periodic liver function tests.

Frequently Asked Questions

Noveze contains ezetimibe and is prescribed to lower elevated cholesterol levels in patients with hypercholesterolemia, familial hypercholesterolemia, homozygous familial hypercholesterolemia, and primary hyperlipidemia, often as part of a broader lipid‑lowering strategy.

Ezetimibe blocks the NPC1L1 transporter on intestinal cells, preventing the absorption of dietary and biliary cholesterol. This leads to reduced cholesterol delivery to the liver, up‑regulation of LDL receptors, and increased removal of LDL‑cholesterol from the bloodstream.

The dose of Noveze is individualized by the prescribing healthcare professional based on the patient’s clinical condition, lipid targets, and any concomitant therapy. The prescriber determines the appropriate strength and dosing schedule.

Safety data for ezetimibe in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Noveze, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative to ezetimibe is statin therapy, which inhibits hepatic cholesterol synthesis. Ezetimibe works by reducing intestinal absorption, and it can be combined with statins for additive LDL‑C reduction. Unlike statins, ezetimibe has a lower risk of muscle‑related side effects but may be less potent when used alone.

Store Noveze at ambient temperature, preferably below 25 °C, in its original packaging. Protect the tablets from moisture and direct light to maintain stability throughout its shelf life.

Noveze is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious adverse events, though rare, include muscle injury (myopathy), significant elevations in liver enzymes, severe allergic reactions such as anaphylaxis, and pancreatitis. Patients should seek immediate medical attention if they experience unexplained muscle pain, jaundice, rash, or intense abdominal pain.

Noveze is contraindicated in patients with known hypersensitivity to ezetimibe or any of its excipients. Caution is advised for individuals with active liver disease, unexplained persistent elevations in hepatic enzymes, or severe gallbladder disease. The prescriber should evaluate each patient’s medical history before initiating therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ezetimibe

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT